• Explore /
  • Poster
  • / A multi-institutional phase II study of high-dose hypofractionated proton beam therapy (HF-PBT) for unresectable primary liver cancers: Long-term outcomes in patients (pts) with hepatocellular carcinoma (HCC).

A multi-institutional phase II study of high-dose hypofractionated proton beam therapy (HF-PBT) for unresectable primary liver cancers: Long-term outcomes in patients (pts) with hepatocellular carcinoma (HCC).

Abstract Poster

Authors

null

Theodore S. Hong

Massachusetts General Hospital, Boston, MA

Theodore S. Hong , Jennifer Yon-Li Wo , Edgar Ben-Josef , Erin McDonnell , Lorraine C. Drapek , Lawrence Scott Blaszkowsky , Eunice Lee Kwak , Jeffrey W. Clark , Lipika Goyal , David P. Ryan , Milind M. Javle , Ronald Arellano , John A. Wolfgang , John Thomas Mullen , Cristina Ferrone , Kenneth Tanabe , Thomas F. DeLaney , Christopher H. Crane , Andrew X. Zhu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT00976898

Citation

J Clin Oncol 34, 2016 (suppl 4S; abstr 376)

DOI

10.1200/jco.2016.34.4_suppl.376

Abstract #

376

Poster Bd #

J12

Abstract Disclosures

Similar Posters

First Author: Ting-Shi Su

First Author: Changhoon Yoo

First Author: Guoliang Shao

First Author: Chi Leung Chiang